← Back to Search

Build Stamina Program for Physical Activity (Build Stamina Trial)

N/A
Waitlist Available
Led By Tara A Albrecht, PhD, ACNP-BC, ACNP-BC, ACHPN
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-weeks
Awards & highlights

Build Stamina Trial Summary

This study is evaluating whether a physical activity program can help improve physical fitness for individuals with acute leukemia.

Eligible Conditions
  • Lung Consolidation
  • Maintenance Therapy
  • Physical Activity
  • Exercise
  • Acute Leukemia

Build Stamina Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Physical Function- 6 Minute walk test
Physical Function- Short Physical Performance Battery Protocol
Secondary outcome measures
Patient-Reported Outcomes- Cognition
Patient-Reported Outcomes-Anxiety
Patient-Reported Outcomes-Depression
+2 more

Build Stamina Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Build Stamina GroupExperimental Treatment1 Intervention
The Build StaMINA (Biobehavioral Self-Management INtervention using physical Activity) is a tailored evidence-based physical activity (PA) program designed to improve endurance, strength, and balance which are all areas of physical function, that adults with acute leukemia (AL) post-induction are known to have diminished capacity. The Build StaMINA program will be tailored to their current Physical Function, per assessment. The detailed PA prescription includes each exercise in the program as well as the frequency, number of repetitions each day and rate of perceived exertion (RPE) for each exercise. The repetitions and RPE are based on the participants' current Physical Function Assessment and will be assigned based on our evidence-based algorithm.
Group II: Attention-Control GroupActive Control1 Intervention
Participants assigned to the attention control group will have a Physical Function Assessment at baseline after informed consent has been provided and prior to randomization. Participants will also be asked to complete questionnaires regarding at baseline, 6-weeks and 3 months. Those in the attention-control group will also receive a newsletter detailing the benefits of participating in regular PA as well as regular phone calls by study team to discuss general health and wellbeing at the same schedule as intervention group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Build Stamina Program
2021
N/A
~50

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,358 Previous Clinical Trials
3,420,020 Total Patients Enrolled
Oncology Nursing SocietyOTHER
10 Previous Clinical Trials
450 Total Patients Enrolled
Tara A Albrecht, PhD, ACNP-BC, ACNP-BC, ACHPNPrincipal InvestigatorDuke University School of Nursing

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Physical Activity to Improve Patient Reported Outcomes for Adults With Acute Leukemia
2021. "Physical Activity to Improve Patient Reported Outcomes for Adults With Acute Leukemia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04552912.
~12 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top